Taylor Financial Group Inc. Makes New Investment in Abbott Laboratories (NYSE:ABT)

Taylor Financial Group Inc. bought a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,295 shares of the healthcare product maker’s stock, valued at approximately $253,000. A number of other hedge funds have also recently […]

Related Keywords

Roberte Funck ,Lisad Earnhardt ,Raymond James ,Perigon Wealth Management ,Visionpoint Advisory Group ,Abbott Laboratories ,Abbott Laboratories Company Profile ,Goldman Sachs Group ,Citigroup ,Wealth Management ,Barclays ,Securities Exchange Commission ,Gradient Investments ,Taylor Financial Group Inc ,Sanibel Captiva Trust Company Inc ,Taylor Financial Group ,Free Report ,Point Advisory Group ,Captiva Trust Company ,Exchange Commission ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Abbott Laboratories Daily ,